Boston Scientific Corporation (ETR:BSX)
Germany
· Delayed Price · Currency is EUR 92.40
+0.80 (0.87%)
Last updated: May 8, 2025
Boston Scientific Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 2,033 | 1,854 | 1,593 | 698 | 1,041 | -82 | Upgrade
|
Depreciation & Amortization | 1,290 | 1,269 | 1,196 | 1,136 | 1,093 | 1,123 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | - | 22 | -78 | - | Upgrade
|
Asset Writedown & Restructuring Costs | 386 | 386 | 58 | 132 | 370 | 533 | Upgrade
|
Loss (Gain) From Sale of Investments | 105 | 79 | 59 | 1 | -250 | -333 | Upgrade
|
Stock-Based Compensation | 277 | 266 | 233 | 220 | 194 | 170 | Upgrade
|
Other Operating Activities | 118 | 43 | 134 | 322 | -149 | 120 | Upgrade
|
Change in Accounts Receivable | -344 | -351 | -238 | -220 | -279 | 335 | Upgrade
|
Change in Inventory | -213 | -228 | -660 | -321 | -346 | -65 | Upgrade
|
Change in Accounts Payable | 308 | 243 | 118 | -255 | 408 | -28 | Upgrade
|
Change in Other Net Operating Assets | -148 | -126 | 10 | -209 | -134 | -265 | Upgrade
|
Operating Cash Flow | 3,812 | 3,435 | 2,503 | 1,526 | 1,870 | 1,508 | Upgrade
|
Operating Cash Flow Growth | 53.90% | 37.23% | 64.02% | -18.40% | 24.01% | -17.87% | Upgrade
|
Capital Expenditures | -798 | -790 | -711 | -588 | -554 | -376 | Upgrade
|
Sale of Property, Plant & Equipment | 3 | 3 | 4 | 12 | 14 | 12 | Upgrade
|
Cash Acquisitions | -4,832 | -4,640 | -1,811 | -1,542 | -2,258 | -3 | Upgrade
|
Divestitures | - | - | - | 5 | 826 | 15 | Upgrade
|
Sale (Purchase) of Intangibles | 20 | 20 | 30 | 70 | 82 | 87 | Upgrade
|
Investment in Securities | -291 | -280 | -89 | -24 | 279 | -146 | Upgrade
|
Other Investing Activities | -4 | - | 3 | 56 | 14 | - | Upgrade
|
Investing Cash Flow | -5,902 | -5,687 | -2,574 | -2,011 | -1,597 | -411 | Upgrade
|
Short-Term Debt Issued | - | 211 | - | - | - | 4,161 | Upgrade
|
Long-Term Debt Issued | - | 2,145 | - | 3,270 | - | 1,683 | Upgrade
|
Total Debt Issued | 1,769 | 2,356 | - | 3,270 | - | 5,844 | Upgrade
|
Short-Term Debt Repaid | - | -504 | -4 | -251 | - | -5,583 | Upgrade
|
Long-Term Debt Repaid | - | -25 | - | -3,184 | - | -1,260 | Upgrade
|
Total Debt Repaid | -1,311 | -529 | -4 | -3,435 | - | -6,843 | Upgrade
|
Net Debt Issued (Repaid) | 458 | 1,827 | -4 | -165 | - | -999 | Upgrade
|
Issuance of Common Stock | 265 | 230 | 182 | 136 | 110 | 1,086 | Upgrade
|
Repurchase of Common Stock | -87 | -87 | -56 | -53 | - | -535 | Upgrade
|
Preferred Dividends Paid | - | - | -28 | -55 | -55 | -28 | Upgrade
|
Dividends Paid | - | - | -28 | -55 | -55 | -28 | Upgrade
|
Other Financing Activities | -158 | -156 | -89 | -411 | -150 | -206 | Upgrade
|
Financing Cash Flow | 478 | 1,814 | 5 | -548 | -95 | 293 | Upgrade
|
Foreign Exchange Rate Adjustments | 35 | -11 | -4 | -9 | -6 | -2 | Upgrade
|
Miscellaneous Cash Flow Adjustments | -1 | -1 | - | - | 1 | - | Upgrade
|
Net Cash Flow | -1,578 | -450 | -70 | -1,042 | 173 | 1,388 | Upgrade
|
Free Cash Flow | 3,014 | 2,645 | 1,792 | 938 | 1,316 | 1,132 | Upgrade
|
Free Cash Flow Growth | 77.50% | 47.60% | 91.05% | -28.72% | 16.25% | -17.67% | Upgrade
|
Free Cash Flow Margin | 17.17% | 15.79% | 12.58% | 7.40% | 11.07% | 11.42% | Upgrade
|
Free Cash Flow Per Share | 2.02 | 1.78 | 1.22 | 0.65 | 0.92 | 0.80 | Upgrade
|
Cash Interest Paid | 250 | 250 | 259 | 450 | 338 | 359 | Upgrade
|
Cash Income Tax Paid | 656 | 656 | 512 | 662 | 302 | 207 | Upgrade
|
Levered Free Cash Flow | 2,315 | 1,808 | 1,880 | 1,155 | 2,654 | 1,110 | Upgrade
|
Unlevered Free Cash Flow | 2,514 | 1,998 | 2,046 | 1,449 | 2,867 | 1,336 | Upgrade
|
Change in Net Working Capital | 304 | 643 | 213 | 660 | -912 | 263 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.